The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation

Cell Motility and the Cytoskeleton

Volumn 39, Issue 3, 1998, Pages 209-222

  Zhu, Dan ^a   Bourguignon, Lilly Y W ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Ankyrin binding; CD44s; Cell adhesion; Cell transformation; Hyaluronic acid; Prostate tumor cells

Indexed keywords

ANKYRIN; COMPLEMENTARY DNA; HERMES ANTIGEN; HYALURONIC ACID; PROTEIN KINASE P60; SYNTHETIC PEPTIDE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BINDING SITE; CELL ADHESION; CELL TRANSFORMATION; DELETION MUTANT; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN BINDING; PROTEIN DOMAIN; REGULATORY MECHANISM; TUMOR CELL;

EID: 0031929182     PISSN: 08861544     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0169(1998)39:3<209::aid-cm4>3.0.co;2-%23     Document Type: Article

References (61)

1. Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., and Zoller, M. (1992): Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257:682-685.
2. Bennett, V. (1992): Ankyrins: Adaptors between diverse plasmamembrane proteins and cytoplasm. J. Biol. Chem. 267:8703-8706.
3. Bennett, V., and Stenbuck, P.S. (1980): Human erythrocyte ankyrin: Purification and properties. J. Biol. Chem. 255:2540-2548.
4. Bennett, K.L., Jackson, D.G., Simon, J.C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., and Aruffo, A. (1995): CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell Biol. 128:687-698.
5. Bourguignon, .Y.W. (1996): Interactions between the membrane-cytoskeleton and CD44 during lymphocyte signal transduction and cell adhesion. Curr. Top. Membr. 43:293-312.
6. 2+ release. J. Biol. Chem. 270:7257-7260.
7. Bourguignon, L.Y.W., Kalomiris, E.L., and Lokeshwar, V.B. (1991): Acylation of the lymphoma transmembrane glycoprotein, GP85 may be required for GP85-ankyrin interaction. J. Immunol. 151:11761-11765.
8. 2+ from storage vesicles in mouse T-lymphoma cells. J. Biol. Chem. 268:7290-7297.
9. Bourguignon, L.Y.W., Lokeshwar, V.B., and Kerrick, W.G. (1993b): Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J. Immunol. 151:6634-6644.
10. 2+ release in T-lymphoma cells. J. Biol. Chem. 270:17917-17922.
11. Bourguignon, L.Y.W., Iida, N., Welsh, C.F., Zhu, D., Krongrad, A., and Pasquale, D. (1995b): Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. J. Neuro-Oncol. 26:201-208.
12. HER2, promotes human ovarian tumor cell activation. J. Biol. Chem. 272:27913-27918.
13. Cao, L., Yoshino, T., Nishiuchi, R., Yamadori, I., and Akagi, T. (1995): Homotypic cell aggregation via conformational change of CD44 molecule induced by anti-CD44 monoclonal antibodies. Immunobiol. 193:1-14.
14. Davis, L., and Bennett, V. (1990): Mapping the binding sites of human erythrocyte ankyrin of the anion exchanger and spectrin. J. Biol. Chem. 265:10589-10596.
15. Dikic, I., Tokiwa, G., Lev, S., Courtneidge, S.A., and Schlessinger, J. (1996): A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383:547-550.
16. Entwistle, J., Hall, C.L., and Turley, E.A. (1996): HA receptors: Regulators of signalling to the cytoskeleton. J. Cell Biochem. 61:569-577.
17. Frank, P.J., and Speck, J.C. (1978): Protein and cell membrane iodination with a sparingly soluble chloramide 1,3,4,6-tetrachloro3a,6a-diphenylglycol. Biochem. Biophys. Res. Commun. 80:849-857.
18. Freedman, V.H., and Shin, S (1974): Cellular tumorigeneicity in nude mice: Correlation with cell growth in semi-solid medium. Cell 3:355-359.
19. Heider, K.H., Hofmann, M., Hors, E., Berg, F.V.D., Ponta, H., Herrlich, P., and Pals, S.T. (1993): A human homologue of the rat metastasis associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell. Biol. 120:227-233.
20. Hirao, M., Sato, N., Kondo, T., Yonemura, S., Monden, M., Sasaki, T., Takai, Y., Tsukita, Sh., and Tsukita, Sa. (1996): Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and rho-dependeru signaling pathway. J. Cell Biol. 135:36-51.
21. Hofmann, M., Rudy, W., Gunthert, U., Zimmer, S.G., Zawadzki, V., Zoller, M., Lichtner, R.B., Herrlich, P., and Ponta, H. (1993): A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53:1516-1521.
22. Horst, E., Meijer, C.J., Radaszkiewicz, T., Ossekoppele, G.J., Van Krieken, J. H., and Pals, S.T. (1990): Adhesion molecules in the prognosis of diffuse large-cell lymphoma: Expression of a lymphocyte homing receptor (CD44), LFA (CD11a/18), and ICAM-1 (CD54). Leukemia 4:595-599.
23. Hunter, T., and Cooper, J.A. (1985): Protein-tyrosine kinase. Annu. Rev. Biochem. 54:897-930.
24. Iida, N., and Bourguignon, L.Y.W. (1995): New CD44 splice variants associated with human breast cancer. J. Cell. Physiol. 162:127-133.
25. Iida, N., and Bourguignon, L.Y.W. (1997): Coexpression of CD44 variant (v10/ex14) and CD44s in human mammary epithelial cells promotes tumorigenesis. J. Cell. Physiol. 171:152-160.
26. Isacke, C.M. (1994). The role of cytoplasmic domain in regulating CD44 function. J. Cell Sci. 107:2353-2359.
27. Jalkanen, S., Joensuu, H., Soderstrom, K.O., and Klemi, P. (1991): Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87:1835-1840.
28. Kalomiris, E.L., and Bourguignon, L.Y.W. (1989): Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85 and may function in GP85-ankyrin binding. J. Biol. Chem. 264:8113-8119.
29. Klausner, R., and Samelson, L.E. (1991): T cell antigen receptor activation pathways: The tyrosine kinase connection. Cell 64:875-878.
30. Kordeli, E., and Bennett, V. (1991): Distinct ankyrin isoforms at neuron cell bodies and nodes of Ranvier resolved using erythrocyte ankyrin-deficient mice. J. Cell Biol. 114:1243-1259.
31. Kordeli, E., Lambert, S., and Bennett, V. (1995): Ankyrin G: A new ankyrin gene with neural-specific isoforms localized to the axonal initial segment and node of Ranvier. J. Biol. Chem. 270:2352-2359.
32. Lesley, J., Hyman, R., and Kincade, P.W. (1993): CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
33. Lesley, J., English, N., Perschl, A., Gregoroff, J., and Hyman, R. (1995): Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 182:431-437.
34. Liu, A. Y. (1994): Expression of CD44 in prostate cancer cells. Cancer Lett. 76:63-69.
35. Lokeshwar, V.B., and Bourguignon, L.Y.W. (1991): Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J. Biol. Chem. 266:17983-17989.
36. Lokeshwar, V.B., and Bourguignon, L.Y.W. (1992): The lymphoma transmembrane glycoprotein CD44 (GP85) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J. Biol. Chem. 267:22073-22078.
37. Lokeshwar, V.B., Fregien, N., and Bourguignon, L.Y.W. (1994): Ankyrin binding domain of CD44 (GP85) is required for the expression of hyuluronic acid-mediated adhesion function. J. Cell Biol. 126:1099-1109.
38. Lokeshwar, V.B., Iida, N., and Bourguignon, L.Y.W. (1996): The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J. Biol. Chem. 271:23853-23864.
39. Matsumura, Y., and Tarin, D. (1992): Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053-1058.
40. Mayer, B.J., and Baltimore, D. (1993): Signalling through SH2 and SH3 domains. Trends Cell Biol. 3:8-13.
41. + ATPase in Madin-Darby canine kidney cells and in intact renal tubule cells. J. Cell Biol. 108:455-465.
42. + ATPase and implications for the organization of membrane domains in polarized cells. Nature 328:533-535.
43. Peach, R.J., Hollenbaugh, D., Stamenkovic, I., and Aruffo, A. (1993): Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122:257-264.
44. Ristamaki, R., Joensuu, H., Soderstrom, K.O., and Jalkanen, S. (1995): CD44v6 expression in non-Hodgkin's lymphoma: An association with low histological grade and poor prognosis. J. Pathol. 176:259-267.
45. Screaton, G.R., Bell, M.V., Jackson, D.G., Comelis, F.B., Gerth, U., and Bell, J.I. (1992): Genomic structure of DNA coding the lymphocyte homing receptor CD44 reveals at least 12 alterna- tively spliced exons. Proc. Natl. Acad. Sci. USA 89:12160-12164.
46. 2 gene and identification of the in tragenic restriction fragment length polymorphism. J. Biol. Chem. 264:17532-17543.
47. Smith, P.R., Saccomani, G., Joe, E.H., Angelides, K.J., and Benos, D.J. (1991): Amiloride-sensitive sodium channel is linked to the cytoskeleton in renal epithelial cells. Proc. Natl. Acad. Sci. USA 88:6971-6975.
48. Stamenkovic, I., Aruffo, A., Amiot, M., and Seed, B. (1991): The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10:343-348.
49. Sy, M.S., Guo, Y.J., and Stamenkovic, I. (1991): Distinct effects of two CD44 isoforms on tumor growth in vivo. J. Exp. Med. 174:859-866.
50. Taher, T.E.I., Smit, L., Griffioen, A.W., Schilder-Tol, E.J.M., Borst, J., and Pals, S.T. (1996): Signaling through CD44 is mediated by tyrosine kinases. J. Biol. Chem. 271:2863-2867.
51. Takahashi, K., Stamenkovic, I., Cutler, M., Dasgupta, A., and Tanabe, K.K. (1996): Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J. Biol. Chem. 271:9490-9496.
52. Tanabe, K.K., Ellis, L.M., and Sayer, H. (1993): Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725-726.
53. Tolg, C., Hofmann, M., Herrlich, P., and Ponta, H. (1993): Splicing choice from ten variants exons establishes CD44 variability. Nucleic Acids Res. 21:1225-1229.
54. Tsukita, Sa., Oishi, K., Sato, N., Sagara, I., Kawai, A., and Tsukita, Sh. (1994): ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin based cytoskeletons. J. Cell Biol. 126:391-401.
55. Underbill, C.B. (1992): CD44: The hyaluronan receptor. J. Cell Sci, 103:293-298.
56. Wasilenko, W.J., Payne, D.M., Fitzgerald, D.L., Weber, M.J. (1991): Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene. Mol. Cell Biol. 11:309-321.
57. Welsh, C.F., Zhu, D., and Bourguignon, L.Y.W. (1995): Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J. Cell. Physiol. 164:605-612.
58. West, D.C., and Kumar, S. (1989): The effects of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp. Cell Res. 183:179-196.
59. Yamamoto-hino, M., Sugiyama, T., Hikichi, K., Mattei, M.G., Hasegawa, K., Sekine, S., Sakurada, K., Miyawaki, A., Furuichi, T., Hasegawa, M., and Mikoshiba, K. (1994): Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptor. Receptors and Channels 2:9-22.
60. Yang, B.H., Yang, B.L., Savani, R.C., and Turley, E.A. (1994): Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBOJ. 13:286-296.
61. neu-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Oncogene 12:2309-2314.